Infectious Disease Molecular Diagnostics for Microbiology

Raised £0 Donors 0 Goal £10,199

This cutting edge molecular technology would allow Hampshire Hospitals to expand their portfolio of infectious disease tests and repatriate a number of reference lab tests too. Consequent reduction in turnaround times versus their current standard of care will reduce diagnostic uncertainty and allow them to put septic patients on the correct targeted treatment sooner.

Firstly, as stated above, it will allow HHFT to offer a number of novel paediatric tests not compatible with their current molecular platforms. Once these are established they could offer further rapid novel tests to their adult population at HHFT which is not currently possible, particularly those associated with community acquired pneumonia and sepsis.